000 | 02365ngm a2200469 a 4500 | ||
---|---|---|---|
001 | HST5218 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 200604s2020 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a5218 _bHenry Stewart Talks |
035 | _a(UkLoHST)4266 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aCragg, Mark, _u(University of Southampton, UK) _4spk |
|
245 | 1 | 0 |
_aMonoclonal antibodies in haemato-oncology _h[electronic resource] / _cMark Cragg. |
260 |
_aLondon : _bHenry Stewart Talks, _c2020. |
||
300 |
_a1 online resource (1 streaming video file (45 min.) : _bcolor, sound). |
||
490 | 1 |
_aMonoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Introduction to the development and clinical use of monoclonal antibodies (mAb) in haemato-oncology -- Currently approved mAb for treating cancer -- Direct targeting antibodies -- Rituximab -- Fc gamma receptors (FcgR) as key mediators of cellular immunity -- Macrophages as key effector cells -- B cell deletion as a paradigm for mAb effects -- Type I versus Type II antibodies -- Obinutuzumab -- Immunomodulatory mAb -- Combinations between direct targeting and immunomodulatory mAb. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aAntineoplastic agents. | |
650 | 0 |
_aLymphoma _xChemotherapy. |
|
650 | 0 | _aMonoclonal antibodies. | |
650 | 2 |
_aAntibodies, Monoclonal _xtherapeutic use. |
|
650 | 2 |
_aAntineoplastic Agents _xpharmacology. |
|
650 | 2 | _aAntineoplastic Agents, Immunological. | |
650 | 2 | _aB-Lymphocytes. | |
650 | 2 | _aImmunity, Cellular. | |
650 | 2 |
_aLymphoma _xdrug therapy. |
|
650 | 2 | _aMacrophages. | |
650 | 2 | _aobinutuzumab. | |
650 | 2 |
_aReceptors, IgG _xdrug effects. |
|
650 | 2 |
_aReceptors, IgG _xmetabolism. |
|
650 | 2 |
_aRituximab _xphamacology. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pMonoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/4266/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/30/ _3Series |
999 |
_c76009 _d76009 |